Dexamethasone regulates glutamine synthetase expression in rat skeletal muscles by Vitkovic, Ljubisa et al.
Dexamethasone Regulates Glutamine Synthetase
Expression in Rat Skeletal Muscles
STEPHEN R. MAX1, MASAAKI KONAGAYA1*, YOKO KONAGAYA1*, JOHN W. THOMAS2,
CARL BANNER2 and LJUBISA VITKOVIC2
Department of Neurology
University of Maryland School of Medicine
Baltimore, MD 21201
and
laboratory of Molecular Biology
National Institute of Neurological and Communicative Diseases and Stroke
National Institutes of Health
Bethesda, MD 20205
Short Title: Muscle Glutamine Synthetase
(KASA-CB-162935) E I X A E E T E A S C ' FE B I G U L A T E S N88-25129
G1C1ABIHE S Y N 1 H E T 2 S E f lPBESSJCK IK EAT
SRELEiai BOSCl-IS < B a r y l a n d Cn iv . ) 23 p
CSCI 06B Uuclas
G3/51 01467C7
Send proofs to: °3
.—i
Stephen R. Max, Ph.D. a* -^^:
Department of Neurology =0 ',..^L[
University of Maryland ^3 'i5>-
School of Medicine \
Baltimore, MD 21201 g ;
(301) 528-3436
 K
CO
*Permanent Address:
Department of Neurology
Nara Medical University
840, Shijo-cho, Kashihara
Nara 634, Japan
https://ntrs.nasa.gov/search.jsp?R=19880015745 2020-03-20T06:47:00+00:00Z
ABSTRACT. We studied the regulation of glutamine synthetase by
glucocorticoids in rat skeletal muscles. Administration of
dexamethasone strikingly enhanced glutamine synthetase activity in
plantaris and soleus muscles. The dexamethasone-mediated
induction of glutamine synthetase activity was blocked to a
significant extent by orally administered RU38486, a
glucocorticoid antagonist, indicating the involvement of
intracellular glucocorticoid receptors in the induction. Northern
blot analysis revealed that dexamethasone-mediated enhancement of
glutamine synthetase activity involves dramatically increased
levels of glutamine synthetase mRNA. The induction of glutamine
synthetase was selective in that glutaminase activity of soleus
and plantaris muscles was not increased by dexamethasone.
Furthermore, dexamethasone treatment resulted in only a small
(15%) increase in glutamine synthetase activity in heart.
Accordingly, there was only a slight (if any) change in glutamine
synthetase mRNA level in this tissue. Thus, glucocorticoids
regulate glutamine synthetase gene expression in rat muscles at
the transcriptional level via interaction with intracellular
receptors. Such regulation may be relevant to control of
glutamine production by muscle and to mechanisms underlying
glucocorticoid-induced muscle atrophy.
Glucocorticoids cause marked atrophy of skeletal muscle (1-
4). This atrophy, which appears to involve intracellular
glucocorticoid receptors (4), involves alterations in protein
synthesis (2, 5-10) and, possibly, protein degradation (11-16).
However, the molecular basis of glucocorticoid-mediated muscle
atrophy is not understood. An important step toward understanding
how glucocorticoids cause muscle atrophy is the study of genes
that may be regulated to produce the catabolic response. Such a
gene may be that for glutamine synthetase, the activity of which
is enhanced in L6 muscle cells in vitro and in rat muscles in vivo
following dexamethasone treatment (17-19). Skeletal muscle
synthesizes and releases glutamine, which is a substrate for
energy metabolism in a number of other tissues, including
intestine, fibroblasts, and, possibly, brain (20 - review). Amino
acids derived from degradation of muscle proteins (21) are the
primary source of muscle glutamine; glutamine synthetase is the
synthetic enzyme.
Recently, we demonstrated that dexamethasone caused a
striking increase in the level of glutamine synthetase mRNA in L6
muscle cells in culture (19). However, an in vitro system is
valuable only insofar as it reflects events in the intact
organism. Therefore, we examined the effects of dexamethasone on
rat skeletal muscles in vivo. A major objective was to evaluate
the hypothesis that increased glutamine synthetase is involved in
the catabolic actions of glucocorticoids on muscle (19).
In this report, we provide evidence that glutamine synthetase
activity in rat muscles in vivo is increased by dexamethasone;
that the increase results from enhanced production of glutamine
synthetase mRNA; and, that induct ion of glutamine synthetase is
mediated via intracellular glucocorticoid receptors. By contrast,
dexamethasone exerted min ima l effects on glutamine synthetase
act ivi ty and mRNA level in heart.
Materials and Methods
Mate rials
Male rats (c r l :CD(SO)BR strain, Charles River Breeding Labs,
W i l m i n g t o n , Mass.) weigh ing 200-225 g were used. They were
mainta ined on a schedule of 12 h l igh t and 12 h darkness, and they
were fed Purina Rodent Laboratory Chow (no. 5001, Ralston Pur ina ,
St. Louis, MO) and water ad l i b i t u m . Dexamethasone was
administered s.c. at a doses of 5 mg/kg; RU38486 [lie -(4-
dimethyl ami nophenyl) (17e-hydroxy-17a-(prop;-l-ynyl estra-4,9-dien-
3-one)] was administered p.o. at 50 mg/kg. The dexamethasone dose
was selected because it is effective in elicit ing muscle atrophy
(e.g., 4). The dose of RU38486 was selected because of its
abi l i ty to block muscle glucocorticoid receptors and
glucocorticoid-mediated muscle atrophy in vivo (4). RU38486 was a
gif t of Roussel-UCLAF (Paris, France). L-glutamic acid-Cu-14c],
specific activity 200-250 mCi /mmol , and L-glutamine-[U-1 4C],
specif ic activity 200-250 m C i / m m o l , were purchased from Research
Products International (Mount Prospect, I N ) . The RNA probe vector
pGEM-2, and the in vitro transcription system, Ribo probe, were
from Promega Biotec (Madison, W I ) . All other chemicals were
obtained from Sigma Chemical Co. (St. Louis, MI) .
Inzyme Assays
Glutamine synthetase and glutaminase activities were assayed
using the method of Rowe (22) as described by Smith et al. (17),
except that the glutamate concentration was 5 mM in our glutamine
synthetase assays. These assays separate product from substrate
by ion-exchange chromatography. The substrates were glutamic acid
[U-14C] and glutamine-Cu-^4C], for glutamine synthetase and
glutaminase, respectively. Glutamine synthetase activity in rat
muscles was completely inhibited by 10 yM L-methionine
sulfoximine, a specific inhibitor of this enzyme (22).
Protein
This was determined according to Lowry et a!. (23), using
crystalline bovine serum albumin as standard.
mRNA (Northern Blot) Analysis
Soleus and plantaris muscles and heart were frozen and
pulverized in liquid nitrogen in a mortar and pestle that had been
treated with diethyl pyrocarbonate (24). The powders were stored
at -70°C. Total cellular RNA was isolated from frozen powders of
soleus, plantaris and heart muscles using the guanidine
isothiocyanate procedure of Chirgwin et al_. (25). RNA was
fractionated by electrophoresis through agarose gels containing
formaldehyde (26), transferred to nitrocellulose filters, and
hybridized with a radioactive RNA probe by the method of Southern
(27). The RNA probe was prepared by in vitro transcription (28)
from an EcoRI/Hindlll fragment of the Chinese hamster glutamine
synthetase gene (29) subcloned into pGEM-2, a pUC-12-derived
plasmid containing both SP6 and T7 promoters (28).
Statistical Analysis
This was performed using analysis of variance and Dunnett's
multiple comparisons test (30) or Student's t-test (Table 1).
Results and Discussion
Dexamethasone caused a striking increase in glutamine
synthetase activity in rat soleus and plantaris muscles. The
time-course of the effect of dexamethasone on glutamine synthetase
activity in rat soleus and plantaris muscles is shown in Fig. 1.
Glutamine synthetase activity in both muscles was 2 times the
control values 24 h after dexamethasone administration and
increased to about 6-fold greater than control after 7 daily
injections of the steroid hormone.
Enhancement of glutamine synthetase activity by dexamethasone
probably is mediated via interaction of the steroid hormone with
intracell ular glucocorticoid receptors, which are present in rat
muscles (4, 31). This conclusion is based upon the data of Fig.
2, in which it is seen that RU38486, a potent and selective
glucocorticoid antagonist in a number of tissues (32) including
muscle (4), significantly reduced the dexamethasone-mediated
increase in enzyme activity. Lack of complete inhibition of the
dexamethasone effect by this large dose of RU38486, compared with
complete blockade in vitro (19), may be due to a higher level of
non-specific binding of RU38486 to plasma proteins (34).
Administration of RU38486 by itself was without effect on
glutamine synthetase activity (33). That the induction of
glutamine synthetase is selective for glucocorticoids is shown
further by the data of Fig. 4. Dexamethasone and triamcinolone
acetonide caused major increases in glutamine synthetase.
Progesterone caused a 50% increase in enzyme activity. Muscle is
considered to be devoid of progestin receptors (35,36). The
effect of this steroid hormone on glutamine synthetase, which we
also observed in vitro (19), may be due to direct agonist action
on glucocorticoid receptors in muscle. Such agonist action has
been demonstrated in certain hepatoma cells (37). Estradiol was
effective, albeit less so, than progesterone. Possibly, estrogen
acted directly via estrogen receptors, which are known to exist in
muscle (38). Testosterone was without effect.
Heart muscle glutamine synthetase increased by only 15% (p<
0.05) after 7 days of daily s.c. injections of dexamethasone at 5
mg/kg, in striking contrast to the large increases (+500%) in
enzyme activity in plantaris and soleus muscles (Fig. 4).
The dexamethasone-mediated increase in glutamine synthetase
activity is at least partly a result of an increased level of
glutamine synthetase mRNA. Northern blot analysis (Fig. 5)
demonstrates that glutamine synthetase mRNA (a major band of 3 kb)
was increased dramatically in plantaris muscles from
dexamethasone-treated rats compared with control animals. By
contrast, there was a small, if any, change in glutamine
synthetase mRNA level in heart. Thus, there is good correlation
\
between enhanced glutamine synthetase activity and increased
levels of glutamine synthetase mRNA (Figs. 5 and 6).
Exposure of autoradiograms for prolonged periods revealed a
second smaller (ca. 1.5 Kb) glutamine synthetase mRNA species, in
agreement with Kumar et al_. (39) and Bhandari et al_. (40).
Further work is needed to evaluate whether this smaller species
also is regulated by dexamethasone and to confirm that it codes
for glutamine synthetase.
Induction of glutamine synthetase precedes muscle atrophy and
appears to be a common denominator in atrophy of a number of
causes (18, 33, 42). Therefore, we have hypothesized that
glutamine synthetase may be involved in a fundamental manner in
the process of atrophy.
It has been demonstrated that glucocorticoid hormones are
anabolic in heart muscle, actually causing an increase in protein
synthesis (41). The lack of induction of glutamine synthetase by
dexamethasone in this tissue supports our hypothesis of a role for
glutamine synthetase in glucocorticoid-mediated muscle atrophy
(19). However, our hypothesis is not supported by the observation
that glutamine synthetase activity is enhanced in soleus muscles
from dexamethasone-treated rats (Figs. 2, 3). Soleus muscle is
notoriously resistant to glucocorticoid-mediated muscle atrophy
(e.g., 4). Paradoxically, soleus muscle contains a high level of
cytosolic glucocorticoid receptors (43). The difference in
response to glucocorticoids may reflect the activity patterns of
these muscles. Plantaris is a fast-twitch, fatiguable muscle that
fires phasically; soleus is a slow-twitch, fatigue-resistant
muscle that fires tonically (44). Perhaps the continuous activity
of the soleus muscle protects it from wasting. Indeed,
glucocorticoid-mediated muscle atrophy is reversed by physical
activity (45). It is also possible that differences in rates of
protein turnover between these muscles (46-50) may account for the
disparity in hormonal responsiveness. Further experimentation
will be necessary to evaluate these possibilities.
Glutaminase activity in rat muscles was not induced by
dexamethasone treatment (Table I), indicating that the
dexamethasone effect on glutamine synthetase is selective. In
fact, dexamethasone caused a significant 30% decrease in
glutaminase activity in soleus muscle (Table I). Whether this
decrease is biologically significant is not known.
These data demonstrate that glutamine synthetase is induced
by glucocorticoids in rat muscles; that this induction involves
the activity of intracellular glucocorticoid receptors; and that
it occurs, at least in part, at the transcriptional level. These
observations agree with our data on L6 muscle cells in vitro
(19). To our knowledge, glutamine synthetase appears to be the
first glucocorticoid-induced protein to be identified in skeletal
muscle. It should provide a valuable biochemical marker for
further studies of glucocorticoid hormone-regulated gene
expression in muscle.
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Figure Legends
Fi gure 1: Time-course of the effect of dexamethasone (5
mg/kg) on glutamine. synthetase activity in rat sol BUS and
plantaris muscles. Data are means ± SEM of 6 determinations.
Experimental procedures are described in the text. Significantly
different from control, p < 0.02, plantaris, p < 0.005,
soleus. Significantly different from day 1 control, p< 0.005,
plantaris, p< 0.01, soleus. Significantly different from day
3 control, p< 0.005, soleus and plantaris.
Fi gure 2: Effect of RU38486 on the dexamethasone-mediated
increase in glutamine synthetase activity in rat plantaris
muscle. Dexamethasone was injected s.c. at 5 mg/kg. RU38486 was
administered p.o. at 50 mg/kg. Glutamine synthetase was assayed
after 3 days of administration of dexamethasone (5 mg/kg) and
RU38486 (50 mg/kg). Data are means ± SEM of six determinations.
Experimental procedures are described in the text. Significantly
**different from control, p < 0.005. Significantly different
from the dexamethasone group, p < 0.01. CTL, control, DEX,
dexamethasone.
Figure 3: Steroid hormone specificity of glutamine
synthetase induction in rat plantaris muscles. Steroid hormones
were injected at 5 mg/kg (s.c.). TA, triamcinolone acetonide; £2
estradiol-170 ; P, progesterone; T, testosterone. Glutamine
synthetase was assayed 24 h after a single injection of steroid
hormone. Data are means ± SEM of six determinations (except
control, n = 16). Experimental procedures are described in the
text. *Significantly different from control, p < 0.001.
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Figure 4: Effect of dexamethasone (5 mg/kg, s.c.) on
glutamine synthetase activity in heart, plantaris, and soleus
muscles. Glutamine synthetase was assayed after 7 days of daily
dexamethasone injections. Significantly different from control,
p < 0.05; **Significantly different from control, p < 0.001.
Figure 5: Northern blot analysis of glutamine synthetase
induction by dexamethasone (5 mg/kg, s.c.) in plantaris muscle and
heart after 5 daily injections. Ctl, control; dex,
dexamethasone. Equal (2.5 vg) amounts of total cellular RNA were
applied to the gel in each instance. Experimental procedures are
described in the text. A section of an autoradiogram containing
cellular RNA hybridized to a radiolabeled glutamine synthetase RNA
probe (3 Kb) is shown.
17
Table 1
Glu taminase Activity in Soleus and Plantar is
Muscles of Dexamethasone-Treated Rats
Treatment Soleus Plantaris
(nmols/mg protein/h)
vehicle 76.40 ± 13.39+ 83.54 ± 16.11
*dexamethasone .53.83 ± 7.36 76.67 ± 16.9
Rats were injected wi th dexamethasone da i ly for 7 days, at a dose of 5 mg/kg,
s.c. +Data are means ± SEM, n = 6. S ign i f i can t ly different from control,
p < 0.005.
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